Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS2P54 (ribosomal protein S2 pseudogene 54) is a processed pseudogene in the human genome related to the functional ribosomal protein S2 gene (RPS2)[2][5]. Pseudogenes like RPS2P54 arise from duplication or retrotransposition events and typically do not produce functional proteins, as they acquire disabling mutations or are not transcribed[5][6]. The parent gene, RPS2, encodes a component of the 40S ribosomal subunit, but RPS2P54 itself is nonfunctional and not considered a biological or therapeutic target[2][5][6]. Summary of scientific context: - Pseudogenes are abundant in the human genome, particularly those derived from ribosomal protein genes[5][6]. - They do not participate in physiological processes like protein synthesis, signaling, or disease mechanisms and are not included in therapeutic databases as actionable molecular targets[2][5][6]. - Only the functional ribosomal protein S2 gene (RPS2) is implicated in protein synthesis and disease; the pseudogene RPS2P54 is distinguishable by its lack of functional products and clinical relevance[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 54 (RPS2P54).